4 Jan 2010 10:29
4Β JanuaryΒ 2010
In accordance with the FSA's Disclosure and Transparency Rules sourcebook transitional provision 6, Phytopharm plcΒ ("Phytopharm")Β herebyΒ notifiesΒ the market of the following:
Phytopharm'sΒ issued share capital atΒ 31Β DecemberΒ 2009Β consistedΒ ofΒ 346,677,433Β ordinary shares with voting rights. The Company didΒ not, at that date,Β hold any shares in Treasury, and thereforeΒ the total number of ordinary shares in the Company with voting rights wasΒ 346,677,433.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Phytopharm plc under the FSA's Disclosure and Transparency Rules.
Zoe McGowanCompany Secretary
Follow the stocks